Brief: Viracta Therapeutics Inc Reports Quarterly Net Loss Was Approximately $17.7 Million, Or $0.47 Per Share

Viracta Therapeutics

10/11/2022 21:21

Nov 10 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES UPDATES ON CLINICAL PROGRAMS
    * CASH, CASH EQUIVALENTS AND INVESTMENTS OF $77.1 MILLION AS
OF
SEPTEMBER 30, 2022, PROVIDES PROJECTED RUNWAY INTO MID-2024
    * QTRLY NET LOSS WAS APPROXIMATELY $17.7 MILLION, OR $0.47
PER
SHARE
    * Q3 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2xrRxV 
Further company coverage:  VIRX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))